Welcome to our dedicated page for Amn Healthcare SEC filings (Ticker: AMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AMN Healthcare Services, Inc. (NYSE: AMN) SEC filings page brings together the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. These documents provide detailed information on AMN Healthcare’s financial condition, capital structure, governance and material events affecting its healthcare workforce solutions and staffing business.
Through periodic and current reports, investors can review how AMN Healthcare’s three reportable segments—Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions—contribute to its overall performance. Filings such as annual reports on Form 10-K and quarterly reports on Form 10-Q (when available) typically include segment discussions, risk factors, management’s analysis and notes on non-GAAP measures like adjusted EBITDA and adjusted diluted EPS.
Current reports on Form 8-K highlight specific events, including earnings announcements, senior notes offerings, amendments to the company’s credit agreement, and changes to its by-laws. For example, AMN Healthcare has filed 8-Ks describing the issuance of senior notes due 2031, amendments to its secured revolving credit facility, and the adoption of amended and restated by-laws that align with developments in Delaware law and update stockholder meeting procedures.
On this page, users can also access filings related to capital markets activities and other material agreements, which explain the terms of AMN Healthcare’s debt instruments and covenants. These disclosures help investors understand the company’s leverage, maturity profiles and financial flexibility.
Stock Titan enhances access to these filings with AI-powered summaries that explain key points in plain language. Users can quickly see the main implications of lengthy documents, such as how a new notes offering affects the balance sheet or how governance changes may influence stockholder rights, while still having the option to review the full SEC filings.
The Vanguard Group filed an amendment to a Schedule 13G/A reporting its holdings in AMN Healthcare Services Inc common stock and states it beneficially owns 0 shares (0%) following an internal realignment effective January 12, 2026. The filing explains certain Vanguard subsidiaries will report holdings separately in accordance with SEC Release No. 34-39538.
AMN Healthcare is asking shareholders to vote on five items at its 2026 virtual annual meeting on May 1, 2026. Proposals include electing nine directors, an advisory approval of 2025 executive pay, ratifying KPMG as auditor for 2026, approving an amendment to the 2025 Equity Plan, and a shareholder proposal the Board opposes.
The company highlights 2025 results of $2.7 billion in revenue, $234 million in adjusted EBITDA and $269 million in free cash flow, along with a $285 million reduction in net debt. Management emphasizes technology platforms like WorkWise, ShiftWise Flex and AMN Passport, growing use of AI, and high client and employee satisfaction scores.
Governance features include an independent board chair, annual director elections, majority voting with a resignation policy, proxy access, an aggregate tenure guideline of under ten years for independent directors, and stock ownership guidelines for directors and executives. The Board also outlines its risk oversight, cybersecurity and data privacy programs, sustainability and social impact priorities, and director compensation structure.
AMN Healthcare Services, Inc. files its Annual Report describing a broad U.S. healthcare staffing and workforce solutions business spanning nurse and allied staffing, locum tenens, interim leadership, language services, managed services programs, vendor management systems and recruitment solutions.
The company highlights significant technology investments, including its WorkWise platform, ShiftWise Flex VMS, AMN Passport app and an Event Management System for strike coverage, as well as growing use of automation and AI. Human capital initiatives focus on well-being, development, employee resource groups and diversity.
Risk factors emphasize economic cycles, labor shortages, regulatory and reimbursement changes, technology disruption, cyber and privacy risks, wage-and-hour and malpractice exposure, and high client concentration, with Kaiser accounting for about 22% of 2025 consolidated revenue. The report also notes a $109.5 million goodwill impairment and total indebtedness of $767.1 million as of December 31, 2025.
AMN Healthcare reported mixed fourth quarter and full-year 2025 results, with growth in some areas but sharply lower profitability. Q4 2025 revenue was $748 million, up 2% year over year and 18% sequentially, helped by $124 million of labor disruption revenue in Nurse and Allied Solutions. The quarter still produced a net loss of $7.7 million, or ($0.20) per share, while adjusted diluted EPS fell to $0.22, down 70% from the prior year period.
For full year 2025, revenue was $2.730 billion, down 8%, and AMN recorded a net loss of $95.7 million, or ($2.48) per share. Adjusted diluted EPS dropped to $1.36 from $3.31 in 2024, and adjusted EBITDA declined 31% to $234.5 million as gross margin compressed to 28.3%. Despite weaker earnings, cash flow from operations reached $269 million and total debt was reduced by $285 million to $775 million. For first quarter 2026, the company guides revenue to $1.225–$1.240 billion with an adjusted EBITDA margin of 9.7%–10.2%.
AMN Healthcare Services, Inc. received an amended Schedule 13G from investment entities associated with Millennium. Integrated Core Strategies (US) LLC reports beneficial ownership of 1,780,744 shares of common stock, representing 4.6% of the class.
Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander each report beneficial ownership of 2,005,966 shares, or 5.2% of the common stock. The filing states that, as of December 31, 2025, the reporting persons ceased to be beneficial owners of more than 5% of AMN’s outstanding common stock and certifies that the holdings are not for the purpose of influencing control.
AMN Healthcare Services, Inc. announced that longtime director R. Jeffrey Harris plans to retire from its Board at the company’s 2026 annual meeting of shareholders and will not stand for re-election. The Board intends to nominate Eric Palmer, a veteran healthcare and insurance executive with more than 25 years of leadership experience, including senior roles at The Cigna Group and Evernorth Health Services, to stand for election at that meeting.
The Vanguard Group filed an amended Schedule 13G reporting a significant passive stake in AMN Healthcare Services Inc. Vanguard reports beneficial ownership of 3,634,998 shares of AMN common stock, representing 9.46% of the class as of the event date.
Vanguard reports shared voting power over 334,280 shares and shared dispositive power over all 3,634,998 shares, with no sole voting or dispositive power. The filing states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control. Vanguard also notes an internal realignment on January 12, 2026, after which certain subsidiaries are expected to report beneficial ownership separately while pursuing the same investment strategies.
AMN Healthcare Services chief information and digital officer Mark C. Hagan reported multiple equity compensation transactions on common stock and restricted stock units. On January 15, 2026, several blocks of restricted stock units vested and converted into AMN common shares, with related shares withheld to cover taxes at $19.55 per share.
Following these transactions, Hagan directly owned 44,873 shares of AMN common stock and 36,828 restricted stock units. The filing also records a new grant of 36,828 restricted stock units under the AMN Healthcare 2025 Equity Plan, vesting in three annual tranches. An earlier filing was corrected, reducing the previously reported derivative holdings from 73,656 units to 36,828 units due to an administrative error.
AMN Healthcare Services’ CFO/COO, Brian M. Scott, filed an amended Form 4 to update his equity holdings after January 15, 2026 transactions. The filing shows 8,843 Restricted Stock Units vested into common stock, with 3,592 shares withheld at $19.55 per share for taxes, leaving 13,093 common shares held directly.
After these transactions, he holds 17,956 Restricted Stock Units from a 2025 grant and 40,920 Restricted Stock Units from a new January 15, 2026 grant, each unit representing one share of AMN common stock. The amendment corrects a prior overstatement, clarifying that 40,920, not 81,840, derivative securities were beneficially owned following the reported transaction.